Genetic test for CYP2C9 and VKORC1 genes to guide warfarin dosing for patients with VTE holds a promise of being able to reduce clinical complications. However, lack of evidence and uncertainties surrounding this new technology lead to the question of whether gene testing is cos…
"1" Result
Sort By: